The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cost and resource utilisation for liquid biopsy vs tissue biopsy genotyping in advanced NSCLC: A micro-costing model.
 
David O'Reilly
Consulting or Advisory Role - Janssen
Travel, Accommodations, Expenses - Takeda
 
Carolyn Moloney
No Relationships to Disclose
 
Anthony O'Grady
No Relationships to Disclose
 
David Synnott
No Relationships to Disclose
 
Daniel Ryan
No Relationships to Disclose
 
Michael O'Brien
No Relationships to Disclose
 
Ross Morgan
No Relationships to Disclose
 
Ian Counihan
No Relationships to Disclose
 
Sinead Cuffe
Travel, Accommodations, Expenses - MSD
 
Grzegorz Korpanty
No Relationships to Disclose
 
Lisa Prior
No Relationships to Disclose
 
Stephen Finn
Honoraria - Roche
Research Funding - Amgen (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Robert Cummins
No Relationships to Disclose
 
Sinead Toomey
No Relationships to Disclose
 
Bryan Hennessy
No Relationships to Disclose
 
Jan Sorensen
No Relationships to Disclose
 
Kathleen Bennett
Research Funding - Novartis
 
Parthiban Nadarajan
No Relationships to Disclose
 
Brendan Doyle
No Relationships to Disclose
 
Jarushka Naidoo
Honoraria - Abbvie/Genentech; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Gilead Sciences; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Arcus Biosciences; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Gilead Sciences; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Regeneron; Roche/Genentech; Takeda; Zymeworks
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb; Pfizer